ATE530227T1 - Verwendung von il-18bp-isoformen zur behandlung und/oder vorbeugung neurologischer entzündungskrankheiten - Google Patents

Verwendung von il-18bp-isoformen zur behandlung und/oder vorbeugung neurologischer entzündungskrankheiten

Info

Publication number: ATE530227T1
Authority: AT; Austria
Prior art keywords: isoforms; treat; inflammatory diseases; prevent neurological; neurological inflammatory
Prior art date: 2005-06-03

Application number

AT06763485T

Other languages

English (en)

Inventor

Yves Sagot

Yolande Chvatchko

Anne Corbaz

Original Assignee

Merck Serono Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-03

Filing date

2006-06-02

Publication date

2011-11-15

2006-06-02 Application filed by Merck Serono Sa filed Critical Merck Serono Sa

2011-11-15 Application granted granted Critical

2011-11-15 Publication of ATE530227T1 publication Critical patent/ATE530227T1/de

Links

102000001708 Protein Isoforms Human genes 0.000 title abstract 3
108010029485 Protein Isoforms Proteins 0.000 title abstract 3
208000027866 inflammatory disease Diseases 0.000 title abstract 2
230000000926 neurological effect Effects 0.000 title abstract 2
102100035017 Interleukin-18-binding protein Human genes 0.000 title 1
101710205006 Interleukin-18-binding protein Proteins 0.000 title 1
102000003810 Interleukin-18 Human genes 0.000 abstract 1
108090000171 Interleukin-18 Proteins 0.000 abstract 1
208000012902 Nervous system disease Diseases 0.000 abstract 1
208000025966 Neurological disease Diseases 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Marine Sciences & Fisheries (AREA)
Cell Biology (AREA)
Psychology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT06763485T 2005-06-03 2006-06-02 Verwendung von il-18bp-isoformen zur behandlung und/oder vorbeugung neurologischer entzündungskrankheiten ATE530227T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05104863		2005-06-03
US68805705P	2005-06-07	2005-06-07
PCT/EP2006/062864 WO2006128911A2 (en)	2005-06-03	2006-06-02	Use of il-18bp isoforms for the treatment and/or prevention of neurological inflammatory diseases

Publications (1)

Publication Number	Publication Date
ATE530227T1 true ATE530227T1 (de)	2011-11-15

Family

ID=35058651

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06763485T ATE530227T1 (de)	2005-06-03	2006-06-02	Verwendung von il-18bp-isoformen zur behandlung und/oder vorbeugung neurologischer entzündungskrankheiten

Country Status (17)

Country	Link
US (1)	US8128920B2 (de)
EP (1)	EP1888100B1 (de)
JP (1)	JP5048658B2 (de)
AT (1)	ATE530227T1 (de)
AU (1)	AU2006254106B2 (de)
CA (1)	CA2610691C (de)
CY (1)	CY1112128T1 (de)
DK (1)	DK1888100T3 (de)
ES (1)	ES2376534T3 (de)
HR (1)	HRP20110788T1 (de)
IL (1)	IL187839A (de)
NO (1)	NO339540B1 (de)
PL (1)	PL1888100T3 (de)
PT (1)	PT1888100E (de)
RS (1)	RS52192B (de)
SI (1)	SI1888100T1 (de)
WO (1)	WO2006128911A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7968684B2 (en)	2003-11-12	2011-06-28	Abbott Laboratories	IL-18 binding proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030105057A1 (en) *	1997-03-19	2003-06-05	Yale University	Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment
IL121860A0 (en) *	1997-08-14	1998-02-22	Yeda Res & Dev	Interleukin-18 binding proteins their preparation and use
BR9816013A (pt)	1998-09-01	2003-01-21	Hayashibara Biochem Lab	Proteìna de ligação de interleucina-18
JP4216950B2 (ja) *	1998-09-01	2009-01-28	株式会社林原生物化学研究所	インターロイキン−１８結合蛋白質
PE20011350A1 (es)	2000-05-19	2002-01-15	Vertex Pharma	PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
AU2002224417A1 (en) *	2000-10-18	2002-04-29	Immunex Corporation	Methods for treating il-18 mediated disorders
KR20040030625A (ko) *	2001-05-25	2004-04-09	아레스 트레이딩 에스.에이.	Ｃｎｓ 손상을 치료하거나 예방하기 위한 ｉｌ-18저해물질의 용도
DK1622939T3 (da) *	2003-05-13	2012-04-10	Merck Serono Sa	Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf

2006
- 2006-06-02 RS RS20120014A patent/RS52192B/sr unknown
- 2006-06-02 US US11/915,913 patent/US8128920B2/en active Active
- 2006-06-02 DK DK06763485.7T patent/DK1888100T3/da active
- 2006-06-02 SI SI200631215T patent/SI1888100T1/sl unknown
- 2006-06-02 CA CA2610691A patent/CA2610691C/en active Active
- 2006-06-02 AT AT06763485T patent/ATE530227T1/de active
- 2006-06-02 PL PL06763485T patent/PL1888100T3/pl unknown
- 2006-06-02 PT PT06763485T patent/PT1888100E/pt unknown
- 2006-06-02 JP JP2008514119A patent/JP5048658B2/ja active Active
- 2006-06-02 WO PCT/EP2006/062864 patent/WO2006128911A2/en not_active Ceased
- 2006-06-02 ES ES06763485T patent/ES2376534T3/es active Active
- 2006-06-02 HR HR20110788T patent/HRP20110788T1/hr unknown
- 2006-06-02 EP EP06763485A patent/EP1888100B1/de active Active
- 2006-06-02 AU AU2006254106A patent/AU2006254106B2/en active Active
2007
- 2007-12-03 IL IL187839A patent/IL187839A/en active IP Right Grant
- 2007-12-11 NO NO20076387A patent/NO339540B1/no unknown
2011
- 2011-11-30 CY CY20111101178T patent/CY1112128T1/el unknown

Also Published As

Publication number	Publication date
JP2008542340A (ja)	2008-11-27
EP1888100A2 (de)	2008-02-20
CA2610691A1 (en)	2006-12-07
HRP20110788T1 (hr)	2011-11-30
EP1888100B1 (de)	2011-10-26
US8128920B2 (en)	2012-03-06
AU2006254106B2 (en)	2012-04-26
WO2006128911A2 (en)	2006-12-07
CA2610691C (en)	2015-12-01
IL187839A0 (en)	2008-03-20
AU2006254106A1 (en)	2006-12-07
ES2376534T3 (es)	2012-03-14
NO20076387L (no)	2008-02-29
NO339540B1 (no)	2016-12-27
DK1888100T3 (da)	2012-01-23
RS52192B (sr)	2012-10-31
PL1888100T3 (pl)	2012-03-30
IL187839A (en)	2013-03-24
WO2006128911A3 (en)	2007-03-29
CY1112128T1 (el)	2015-11-04
PT1888100E (pt)	2011-12-15
JP5048658B2 (ja)	2012-10-17
AU2006254106A8 (en)	2008-04-03
US20080233085A1 (en)	2008-09-25
SI1888100T1 (sl)	2012-01-31

Legal Events

Date

Code

Title

Description

2012-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1888100

Country of ref document: EP

Publication	Publication Date	Title
NL301145I2 (nl)	2021-12-07	Tirbanibulin
ATE526991T1 (de)	2011-10-15	Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE429645T1 (de)	2009-05-15	Verwendung von eph-rezeptor-inhibitoren zur behandlung neurodegenerativer krankheiten
ATE480543T1 (de)	2010-09-15	Tetrahydropyrrolopyrimidindione und ihre verwendung als inhibitoren der humanen neutrophilen elastase
MXPA06014510A (es)	2007-09-19	Composiciones y metodos para tratar trastornos inflamatorios.
WO2007022506A3 (en)	2007-05-03	Methods and compositions for treating neurological disease
CY1109985T1 (el)	2014-09-10	Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
ATE456955T1 (de)	2010-02-15	Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
MX2010000956A (es)	2010-03-01	Derivados de isoftalamida que inhiben actividad de beta-secretasa.
ATE542535T1 (de)	2012-02-15	Verwendung von azapaullonen zur vorbeugung und behandlung pankreatischer autoimmunkrankheiten
NO20054913L (no)	2005-12-21	Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
ATE518531T1 (de)	2011-08-15	Alpha-humulene zur verwendung bei der prophylaxe oder behandlung der entzündlichen schmerzen und des ödems
DE602006017367D1 (de)	2010-11-18	Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
ATE397000T1 (de)	2008-06-15	Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
NO20064896L (no)	2006-11-06	Fremgangsmater for behandling av autoimmune og inflammatoriske sykdommer
TW200716132A (en)	2007-05-01	Novel chemical compounds
ATE494903T1 (de)	2011-01-15	Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden
DE602006007323D1 (de)	2009-07-30	VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN
ATE530227T1 (de)	2011-11-15	Verwendung von il-18bp-isoformen zur behandlung und/oder vorbeugung neurologischer entzündungskrankheiten
EA200800342A1 (ru)	2008-08-29	ИНГИБИТОРЫ Glepp-1 ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И/ИЛИ ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ
NO20072048L (no)	2007-05-30	Anvendelse av IL-17F for behandling og/eller forebygging av neurologiske sykdommer.
DE602004022423D1 (de)	2009-09-17	Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz
TW200716579A (en)	2007-05-01	Novel chemical compounds
DE602006018725D1 (de)	2011-01-20	Amidin-derivate zur verwendung in der vorbeugung oder behandlung von glaukom
ATE476185T1 (de)	2010-08-15	Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen